Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus

BACKGROUND: Currently, there are no conclusive results on the efficacy of adefovir dipivoxil (ADV) plus lamivudine (LAM) in LAM-resistant patients with chronic hepatitis B (CHB). The aim of study was to evaluate the efficacy of rescue therapy with ADV plus LAM compared to ADV monotherapy in LAM-resi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, En-Qiang, Wang, Li-Chun, Lei, Jun, Xu, Lu, Tang, Hong
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764700/
https://www.ncbi.nlm.nih.gov/pubmed/19818142
http://dx.doi.org/10.1186/1743-422X-6-163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764700/
https://www.ncbi.nlm.nih.gov/pubmed/19818142
http://dx.doi.org/10.1186/1743-422X-6-163

Ejemplares similares